Pharmaceutical Drug Delivery Market Competitve Landscape 2024-2033 – Major Players and Strategies

 Overview and Scope

Pharmaceutical drug delivery refers to the process or method of administering a drug to an animal or human to achieve a therapeutic effect. It is a formulation or apparatus that allows a medicinal material to target its site of action while avoiding nontarget cells, organs, or tissues.

Sizing and Forecast
The pharmaceutical drug delivery market size has grown strongly in recent years. It will grow from $1711.47 billion in 2023 to $1816.05 billion in 2024 at a compound annual growth rate (CAGR) of 6.1%.  The  growth in the historic period can be attributed to increase in prevalence of chronic diseases, growing demand for biologics, increase in r&d investments by pharmaceutical companies, rising demand for personalized medicine, increased focus on patient compliance.

The pharmaceutical drug delivery market size is expected to see strong growth in the next few years. It will grow to $2337.46 billion in 2028 at a compound annual growth rate (CAGR) of 6.5%.  The growth in the forecast period can be attributed to growing demand for self-administration of drugs, increasing adoption of home healthcare, growing demand for targeted drug delivery, increase in the number of elderly people, regulatory support for drug delivery technologies. Major trends in the forecast period include advancements in drug delivery technologies, telemedicine integration, 3d printing in drug delivery, targeted drug delivery systems, continuous manufacturing processes.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/pharmaceutical-drug-delivery-global-market-report

Segmentation & Regional Insights
The pharmaceutical drug delivery market covered in this report is segmented –
1) By Route of Administration: Oral, Ocular, Pulmonary, Nasal, Injectable, Topical, Other Routes
2) By Application: Infectious Diseases, Cancer, Cardiovascular Diseases, Diabetes, Respiratory Diseases, Central Nervous System Disorders, Autoimmune Diseases, Other Applications
3) By End-User: Hospitals, Home Care Settings, ASC/Clinics, Other End Users

North America was the largest region in the pharmaceutical drug delivery market in 2023. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical drug delivery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6962&type=smp

Major Driver Impacting Market Growth
The growing prevalence of chronic diseases is expected to propel the growth of the pharmaceutical drug delivery market going forward. Prevalence of chronic diseases refers to the total number of existing cases of chronic diseases in a population at a specific time. Pharmaceutical drug delivery helps the patients suffering from chronic diseases by delivering a pharmaceutical drug to a specific part of the body to treat different diseases. For instance, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, noncommunicable diseases kill 41 million people each year, equivalent to 71% of all deaths globally and cardiovascular diseases account for most of the deaths. Therefore, the growing prevalence of chronic diseases is driving the pharmaceutical drug delivery market growth.

Key Industry Players
Major companies operating in the pharmaceutical drug delivery market report are 3M Company., AbbVie Inc., Amgen Inc., AstraZeneca plc, Bayer AG, Becton Dickinson And Company, C. H. Boehringer Sohn AG & Co. KG, Boston Scientific Corporation, Bristol-Myers Squibb Company, Consort Medical plc, Eli Lilly and Company, Emergent Biosolutions Inc., F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Johnson & Johnson, Kite Pharma Inc., Merck & Co Inc., Nemera France SAS, Nimbus Therapeutics LLC, Novartis AG, Pfizer Inc, Sanofi S. A., SHL Medical AG, Teva Pharmaceuticals Industries Ltd., West Pharmaceutical Services Inc., Aerogen Pharma Limited, AptarGroup Inc., Aquitive Therapeutics Inc., Biocon Ltd., Catalent Inc., Evonik Industries AG, Inovio Pharmaceuticals Inc., Mylan NV, Sanofi SA, Sensile Medical Inc., Unilife Corporation, Ypsomed Holding AG, Zosano Pharma Corp.

The pharmaceutical drug delivery market report table of contents includes:
1. Executive Summary

2. Pharmaceutical Drug Delivery Market Characteristics

3. Pharmaceutical Drug Delivery Market Trends And Strategies

4. Pharmaceutical Drug Delivery Market - Macro Economic Scenario

5. Global Pharmaceutical Drug Delivery Market Size and Growth
.
31. Global Pharmaceutical Drug Delivery Market Competitive Benchmarking

32. Global Pharmaceutical Drug Delivery Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Pharmaceutical Drug Delivery Market

34. Pharmaceutical Drug Delivery Market Future Outlook and Potential Analysis

35. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model